Parallel Advisors LLC Buys 136 Shares of Waters Co. (NYSE:WAT)

Parallel Advisors LLC lifted its stake in shares of Waters Co. (NYSE:WAT) by 18.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 856 shares of the medical instruments supplier’s stock after purchasing an additional 136 shares during the quarter. Parallel Advisors LLC’s holdings in Waters were worth $318,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in WAT. Pathstone Holdings LLC grew its holdings in shares of Waters by 1.7% during the 3rd quarter. Pathstone Holdings LLC now owns 3,916 shares of the medical instruments supplier’s stock valued at $1,409,000 after purchasing an additional 65 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in Waters during the 3rd quarter worth approximately $1,631,000. Landscape Capital Management L.L.C. bought a new stake in Waters during the 3rd quarter worth approximately $483,000. Charles Schwab Investment Management Inc. grew its holdings in Waters by 2.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 384,641 shares of the medical instruments supplier’s stock worth $138,428,000 after acquiring an additional 7,865 shares during the last quarter. Finally, Raymond James Trust N.A. grew its holdings in Waters by 2.4% during the 3rd quarter. Raymond James Trust N.A. now owns 1,340 shares of the medical instruments supplier’s stock worth $482,000 after acquiring an additional 32 shares during the last quarter. 94.01% of the stock is owned by institutional investors.

Waters Stock Up 0.7 %

Waters stock opened at $365.75 on Friday. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. Waters Co. has a 12-month low of $279.24 and a 12-month high of $423.56. The firm’s fifty day moving average is $390.80 and its 200 day moving average is $371.28. The company has a market capitalization of $21.73 billion, a PE ratio of 34.15, a PEG ratio of 3.79 and a beta of 1.00.

Waters (NYSE:WAT) last released its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. As a group, sell-side analysts predict that Waters Co. will post 12.86 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on WAT shares. Scotiabank raised shares of Waters from a “sector perform” rating to a “sector outperform” rating and boosted their target price for the stock from $430.00 to $450.00 in a report on Thursday, February 13th. StockNews.com lowered shares of Waters from a “buy” rating to a “hold” rating in a report on Tuesday, February 25th. Sanford C. Bernstein raised shares of Waters from a “market perform” rating to an “outperform” rating and set a $430.00 target price on the stock in a report on Friday, January 10th. Bank of America reduced their target price on shares of Waters from $430.00 to $410.00 and set a “neutral” rating on the stock in a report on Thursday, February 13th. Finally, Barclays raised shares of Waters from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $360.00 to $415.00 in a report on Monday, February 10th. Eleven research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Waters presently has a consensus rating of “Hold” and an average target price of $391.07.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.